
Ranivin 25mg Injection
Marketer
Alpa Laboratories Ltd
Salt Composition
Ranitidine (25mg)
Overview Ranivin 25mg Injection
Gastric acid reduction is achieved with the 25mg Ranivin injection, indicated for hospitalized patients with hyperacidity. It's also employed to treat persistent ulcers unresponsive to alternative therapies. Administration is strictly by a healthcare professional; self-injection is prohibited. Dosage is condition-specific and determined by your physician, whose instructions must be meticulously followed. Relief from indigestion and heartburn is typically observed within hours. Treatment duration varies; short-term use for symptomatic relief versus longer-term prophylaxis against ulcers and related conditions. Consistent usage is crucial for preventing recurrences. Dietary modifications, such as consuming smaller, more frequent meals and avoiding rich or spicy foods, may further alleviate symptoms. Side effects are generally infrequent, but may encompass headache, constipation, fatigue, or diarrhea; these are usually transient. Persistent or bothersome side effects warrant medical consultation. Prior to treatment, disclose any liver or kidney issues, and list all concurrent medications due to potential interactions. Generally safe during pregnancy and breastfeeding under medical supervision, alcohol consumption should be avoided to prevent exacerbated symptoms.
Uses of Ranivin 25mg Injection
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Ranivin 25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ranivin 25mg Injection:
- Headache
- Diarrhea
- Gastrointestinal disturbance
How to use Ranivin 25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Ranivin 25mg Injection works:
Histamine H2 receptor antagonist Ranivin 25mg Injection decreases gastric acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Ranivin 25mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Ranivin 25mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Maternal use of Ranivin 25mg Injection while breastfeeding carries a likely risk. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible threat to the infant.
DrivingSAFE
Driving ability is typically unaffected by Ranivin 25mg Injection.
KidneyCAUTION
Individuals with impaired kidney function should use Ranivin 25mg Injection cautiously. A modified dosage of Ranivin 25mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should use Ranivin 25mg Injection cautiously. Dosage modification of Ranivin 25mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Ranivin 25mg Injection :
Should you forget a Ranivin 25mg Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Ranivin 25mg Injection
| Label | Value |
|---|---|
| Pharmaceutical Classification | Arylalkylamine analog |
| Potential for Dependence | None. |
| Type of Medication | Stomach and intestinal |
